Geisler, Tobias <br/><br/>
Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials.  [electronic resource] 

 -  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology  May 2014 
 - 97-104 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1969-6213 
<br/><br/><label>Standard No.: </label>10.4244/EIJV10I1A16  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--therapeutic use<br/>Anticoagulants--therapeutic use<br/>Antithrombins--therapeutic use<br/>Coronary Artery Disease--therapy<br/>Eptifibatide<br/>Female<br/>Fibrinolytic Agents--therapeutic use<br/>Hemorrhage--prevention & control<br/>Heparin--therapeutic use<br/>Hirudins<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Male<br/>Middle Aged<br/>Peptide Fragments--therapeutic use<br/>Peptides--therapeutic use<br/>Percutaneous Coronary Intervention--methods<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Randomized Controlled Trials as Topic<br/>Recombinant Proteins--therapeutic use<br/>Treatment Outcome